Marshall Wace LLP Sells 7,467 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Marshall Wace LLP decreased its holdings in Huron Consulting Group Inc. (NASDAQ:HURN) by 5.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 127,074 shares of the business services provider’s stock after selling 7,467 shares during the quarter. Marshall Wace LLP’s holdings in Huron Consulting Group were worth $12,517,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in Huron Consulting Group during the fourth quarter valued at $14,460,000. PNC Financial Services Group Inc. lifted its position in shares of Huron Consulting Group by 39.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 2,555 shares of the business services provider’s stock valued at $263,000 after buying an additional 724 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Huron Consulting Group by 4.2% during the 4th quarter. Franklin Resources Inc. now owns 9,927 shares of the business services provider’s stock valued at $1,020,000 after acquiring an additional 396 shares during the period. Alberta Investment Management Corp increased its holdings in Huron Consulting Group by 12.1% in the 4th quarter. Alberta Investment Management Corp now owns 32,625 shares of the business services provider’s stock worth $3,354,000 after acquiring an additional 3,532 shares in the last quarter. Finally, CenterBook Partners LP raised its stake in Huron Consulting Group by 15.9% during the 4th quarter. CenterBook Partners LP now owns 10,805 shares of the business services provider’s stock worth $1,111,000 after acquiring an additional 1,485 shares during the period. 93.90% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Huron Consulting Group

In other news, Director H Eugene Lockhart sold 1,042 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $109.48, for a total transaction of $114,078.16. Following the sale, the director now directly owns 29,882 shares of the company’s stock, valued at approximately $3,271,481.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director H Eugene Lockhart sold 1,042 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $109.48, for a total value of $114,078.16. Following the completion of the transaction, the director now owns 29,882 shares of the company’s stock, valued at approximately $3,271,481.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO C. Mark Hussey sold 34,013 shares of the business’s stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $100.69, for a total value of $3,424,768.97. Following the sale, the chief executive officer now directly owns 85,081 shares in the company, valued at $8,566,805.89. The disclosure for this sale can be found here. Insiders sold 44,439 shares of company stock worth $4,512,214 in the last quarter. 2.02% of the stock is owned by corporate insiders.

Analyst Ratings Changes

HURN has been the subject of a number of recent analyst reports. Benchmark reiterated a “buy” rating and issued a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, July 31st. Barrington Research reaffirmed an “outperform” rating and issued a $137.00 target price on shares of Huron Consulting Group in a report on Monday, September 9th. Finally, StockNews.com raised Huron Consulting Group from a “sell” rating to a “hold” rating in a report on Saturday, August 3rd. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $131.75.

Huron Consulting Group Price Performance

Shares of NASDAQ:HURN opened at $108.01 on Friday. The firm has a market cap of $1.94 billion, a price-to-earnings ratio of 31.13 and a beta of 0.61. The firm has a fifty day moving average price of $107.35 and a 200 day moving average price of $98.69. Huron Consulting Group Inc. has a fifty-two week low of $84.26 and a fifty-two week high of $115.65. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.93 and a current ratio of 1.93.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings data on Tuesday, July 30th. The business services provider reported $1.68 EPS for the quarter, beating the consensus estimate of $1.48 by $0.20. Huron Consulting Group had a net margin of 5.46% and a return on equity of 20.44%. The business had revenue of $371.70 million during the quarter, compared to the consensus estimate of $374.33 million. During the same quarter in the prior year, the firm earned $1.38 EPS. The business’s revenue was up 7.2% on a year-over-year basis. As a group, sell-side analysts expect that Huron Consulting Group Inc. will post 5.95 earnings per share for the current fiscal year.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.